A First-In-Human Phase 1 Trial Of Nx-2127, A First-In-Class Oral Btk Degrader With Imid-Like Activity, In Patients With Relapsed And Refractory B-Cell Malignancies
NX-2127
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A First-In-Human Phase 1 Trial Of Nx-2127, A First-In-Class Oral Btk Degrader With Imid-Like Activity, In Patients With Relapsed And Refractory B-Cell Malignancies ### Output: NX-2127